Neogen Chemicals Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company also approved several material related party transactions, including granting corporate guarantees up to ₹500 crore and increasing thresholds for loans and investments. These approvals are subject to shareholder consent and are aimed at facilitating business operations and growth initiatives.
Q2 FY27 Financial Highlights
Neogen Chemicals Limited has disclosed its unaudited financial results for the quarter and half-year ended September 30, 2026. The standalone financial results show a revenue from operations of ₹288.00 crore for the quarter and ₹540.28 crore for the half-year. Profit after tax for the period stood at ₹21.14 crore and ₹40.58 crore respectively. The consolidated results reported revenue from operations of ₹295.96 crore and ₹546.25 crore for the respective periods, with a profit after tax of ₹8.23 crore and ₹25.34 crore.
Material Related Party Transactions Approved
The Board of Directors also approved various material related party transactions (RPTs). Key among these include:
- Granting corporate guarantees, securities, or indemnities to Neogen Morita New Materials Limited (NML), a step-down subsidiary, up to ₹500 crore.
- Approving an increase in the threshold for granting loans/ICDs, providing corporate guarantees/securities, and making investments in securities up to ₹500 crore.
- Approving multiple transactions between Neogen Ionics Limited (NIL), a wholly-owned subsidiary, and NML, covering loans, guarantees, sale/purchase of goods, leasing, services, and infrastructure sharing, with individual transaction limits ranging up to ₹500 crore.
These transactions, expected to exceed materiality thresholds, require shareholder approval via an ordinary resolution. They are to be conducted in the ordinary course of business and on an arm’s length basis.
Other Business Developments
The company also approved the early redemption of outstanding non-cumulative, non-convertible debentures worth ₹200 crore. Furthermore, it announced plans to expand its Organo-Lithium chemicals manufacturing facility at Patancheru, Telangana, with an estimated investment of up to ₹45 crore, aiming to double capacity and significantly increase revenue potential.
The Board further approved the notice for a postal ballot to seek shareholder approval for the outlined RPTs and other resolutions.
Source: BSE
